According to a recently published report, the global Medical Plastic is expected to grow at the CAGR of 10.12% during 2015-2022 and it estimated to be $ 7.54 billion by 2022. The global medical plastic is segmented on the basis of by type, by applications, and geography. The report on global Medical Plastic forecast, 2012-2022 (by type, by applications, and geography) provides detailed overview and predictive analysis of the market.
Full report available global medical plastic forecast, 2012-2022 (by type, by applications, and geography) report at http://www.briskinsights.com/report/medical-plastics-market
The global medical plastic is expected to grow exponentially due changing agrochemicals usage patterns of pesticides followed by increased global population & consumer health awareness, as reported by, Brisk Insights. The global medical plastics market is majorly driven by factors like growing awareness regarding benefits of using medical polymers with biocide properties is expected to drive market demand. In addition, increasing popularity of lightweight, low cost, portable and small devices in healthcare industry is likely to propel further industry expansion.
The application market for Medical Plastics Market is segmented as follows: by type, by application and by geography. Medical plastics market is bifurcated into product types and application segment. North America dominated the global market presently, accounting for over 43% of the volume share and is expected to grow substantially on account of technological development and significant investments in R&D. Moreover, increasing need for advanced instruments with better performance and higher strength and flexibility, mainly in the US, is likely to perpetuate growth.
Medical plastics market is fragmented in nature with prominent players investing majorly on increasing market penetration in untapped Asia Pacific market. The companies such as Phillips-Medisize Corporation (U.S.), Freudenberg Medical (U.S.), Nolato AB (Sweden), Röchling Engineering Plastics (Germany), and West Pharmaceutical Services, Inc. (U.S.), are the dominant market players in the global market.
Release ID: 1617